127 related articles for article (PubMed ID: 17989113)
1. Anti-LOX-1 therapy in rats with diabetes and dyslipidemia: ablation of renal vascular and epithelial manifestations.
Dominguez JH; Mehta JL; Li D; Wu P; Kelly KJ; Packer CS; Temm C; Goss E; Cheng L; Zhang S; Patterson CE; Hawes JW; Peterson R
Am J Physiol Renal Physiol; 2008 Jan; 294(1):F110-9. PubMed ID: 17989113
[TBL] [Abstract][Full Text] [Related]
2. LOX-1 and inflammation: a new mechanism for renal injury in obesity and diabetes.
Kelly KJ; Wu P; Patterson CE; Temm C; Dominguez JH
Am J Physiol Renal Physiol; 2008 May; 294(5):F1136-45. PubMed ID: 18322020
[TBL] [Abstract][Full Text] [Related]
3. Postischemic inflammatory syndrome: a critical mechanism of progression in diabetic nephropathy.
Kelly KJ; Burford JL; Dominguez JH
Am J Physiol Renal Physiol; 2009 Oct; 297(4):F923-31. PubMed ID: 19656916
[TBL] [Abstract][Full Text] [Related]
4. Renal injury: similarities and differences in male and female rats with the metabolic syndrome.
Dominguez JH; Wu P; Hawes JW; Deeg M; Walsh J; Packer SC; Nagase M; Temm C; Goss E; Peterson R
Kidney Int; 2006 Jun; 69(11):1969-76. PubMed ID: 16688121
[TBL] [Abstract][Full Text] [Related]
5. Elevation of circulating LOX-1 ligand levels in Zucker obese and diabetic rats.
Wakabayashi I; Shimomura T; Nakanishi M; Uchida K
Obes Res Clin Pract; 2015; 9(1):26-30. PubMed ID: 25434992
[TBL] [Abstract][Full Text] [Related]
6. Blockade of cysteine-rich protein 61 attenuates renal inflammation and fibrosis after ischemic kidney injury.
Lai CF; Lin SL; Chiang WC; Chen YM; Wu VC; Young GH; Ko WJ; Kuo ML; Tsai TJ; Wu KD
Am J Physiol Renal Physiol; 2014 Sep; 307(5):F581-92. PubMed ID: 24920753
[TBL] [Abstract][Full Text] [Related]
7. Dyslipidemia-induced neuropathy in mice: the role of oxLDL/LOX-1.
Vincent AM; Hayes JM; McLean LL; Vivekanandan-Giri A; Pennathur S; Feldman EL
Diabetes; 2009 Oct; 58(10):2376-85. PubMed ID: 19592619
[TBL] [Abstract][Full Text] [Related]
8. Intravenous renal cell transplantation with SAA1-positive cells prevents the progression of chronic renal failure in rats with ischemic-diabetic nephropathy.
Kelly KJ; Zhang J; Han L; Wang M; Zhang S; Dominguez JH
Am J Physiol Renal Physiol; 2013 Dec; 305(12):F1804-12. PubMed ID: 24133118
[TBL] [Abstract][Full Text] [Related]
9. JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, improves hyperglycemia and dyslipidemia independent of suppression of food intake in diabetic rats.
Sakata S; Ito M; Mera Y; Sasase T; Yamamoto H; Kakutani M; Ohta T
J Diabetes Res; 2014; 2014():803832. PubMed ID: 24895641
[TBL] [Abstract][Full Text] [Related]
10. Taurine rescues vascular endothelial dysfunction in streptozocin-induced diabetic rats: correlated with downregulation of LOX-1 and ICAM-1 expression on aortas.
Wang LJ; Yu YH; Zhang LG; Wang Y; Niu N; Li Q; Guo LM
Eur J Pharmacol; 2008 Nov; 597(1-3):75-80. PubMed ID: 18796303
[TBL] [Abstract][Full Text] [Related]
11. Potential renoprotective effects of piceatannol in ameliorating the early-stage nephropathy associated with obesity in obese Zucker rats.
Llarena M; Andrade F; Hasnaoui M; Portillo MP; Pérez-Matute P; Arbones-Mainar JM; Hijona E; Villanueva-Millán MJ; Aguirre L; Carpéné C; Aldámiz-Echevarría L
J Physiol Biochem; 2016 Sep; 72(3):555-66. PubMed ID: 26660756
[TBL] [Abstract][Full Text] [Related]
12. Lipotoxic and inflammatory phenotypes in rats with uncontrolled metabolic syndrome and nephropathy.
Dominguez J; Wu P; Packer CS; Temm C; Kelly KJ
Am J Physiol Renal Physiol; 2007 Sep; 293(3):F670-9. PubMed ID: 17596532
[TBL] [Abstract][Full Text] [Related]
13. Renal function and structure in diabetic, hypertensive, obese ZDFxSHHF-hybrid rats.
Tofovic SP; Kusaka H; Kost CK; Bastacky S
Ren Fail; 2000; 22(4):387-406. PubMed ID: 10901178
[TBL] [Abstract][Full Text] [Related]
14. Studies of renal injury III: lipid-induced nephropathy in type II diabetes.
Dominguez JH; Tang N; Xu W; Evan AP; Siakotos AN; Agarwal R; Walsh J; Deeg M; Pratt JH; March KL; Monnier VM; Weiss MF; Baynes JW; Peterson R
Kidney Int; 2000 Jan; 57(1):92-104. PubMed ID: 10620191
[TBL] [Abstract][Full Text] [Related]
15. Oxidized LDL receptor LOX-1 is involved in neointimal hyperplasia after balloon arterial injury in a rat model.
Hinagata J; Kakutani M; Fujii T; Naruko T; Inoue N; Fujita Y; Mehta JL; Ueda M; Sawamura T
Cardiovasc Res; 2006 Jan; 69(1):263-71. PubMed ID: 16183045
[TBL] [Abstract][Full Text] [Related]
16. Rosiglitazone treatment restores renal dopamine receptor function in obese Zucker rats.
Umrani DN; Banday AA; Hussain T; Lokhandwala MF
Hypertension; 2002 Dec; 40(6):880-5. PubMed ID: 12468573
[TBL] [Abstract][Full Text] [Related]
17. LOX-1, an oxidized low-density lipoprotein receptor, was upregulated in the kidneys of chronic renal failure rats.
Ueno T; Kaname S; Takaichi K; Nagase M; Tojo A; Onozato ML; Fujita T
Hypertens Res; 2003 Jan; 26(1):117-22. PubMed ID: 12661921
[TBL] [Abstract][Full Text] [Related]
18. Cross-talk between dyslipidemia and renin-angiotensin system and the role of LOX-1 and MAPK in atherogenesis studies with the combined use of rosuvastatin and candesartan.
Chen J; Li D; Schaefer R; Mehta JL
Atherosclerosis; 2006 Feb; 184(2):295-301. PubMed ID: 16005008
[TBL] [Abstract][Full Text] [Related]
19. Oxidized LDL receptor LOX-1 binds to C-reactive protein and mediates its vascular effects.
Fujita Y; Kakino A; Nishimichi N; Yamaguchi S; Sato Y; Machida S; Cominacini L; Delneste Y; Matsuda H; Sawamura T
Clin Chem; 2009 Feb; 55(2):285-94. PubMed ID: 19074514
[TBL] [Abstract][Full Text] [Related]
20. Treatment of the post-ischaemic inflammatory syndrome of diabetic nephropathy.
Kelly KJ; Dominguez JH
Nephrol Dial Transplant; 2010 Oct; 25(10):3204-12. PubMed ID: 20466672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
